Objective: To investigate the in vivo oxidation of 13 C18X2n-6 and its conversion into longer-chain polyunsaturates (LCPs) in healthy subjects. Design: Blood samples were collected from six subjects before (fasted) and 7, 11 (non-fasted), 24, 48, 72, 168 and 336 h (fasted) after ingestion of a single bolus of 45 mg uniformly labeled 13 C18X2n-6 dissolved in 8 g olive oil. In three subjects, breath was also sampled and CO 2 production measured every hour during the ®rst 12 h. Subjects consumed their habitual diets. Plasma 13 C-enrichments were measured by GC-C-IRMS and fatty acid compositions by GCaFID. Setting: Maastricht University, Department of Human Biology. Subjects: Three men and three women, recruited by local advertisement. Results: The traceratracee ratio (TTR) of C18X2n-6 in plasma total lipids was already increased 5 h after tracer intake. The mean peak amount (AE s.e.m) of 13 C18X2n-6 (3.4AE 0.8 mg; 7.6% of dose) was found after about 17 h, 13 C18X3n-6 (0.018 AE 0.008 mg; 0.04% of dose) after 7 ± 48 h, and 13 C20X3n-6 (0.028 AE 0.011 mg; 0.06% of dose) after 48 ± 336 h. Time to peak TTRs of C20X4n-6 varied between subjects and were on average 0.022 AE 0.006 mg (0.05% of dose). The proportion of 13 C18X2n-6 recovered in breath after 12 h ranged between 16.8 and 25.1%. Conclusions: These ®ndings suggest that a single bolus of 45 mg U-13 C18X2n-6 can be used to study the oxidation of 13 C18X2n-6. However, because of the low TTRs for C20X4n-6, a higher dose is recommended for studying the conversion of 13 C18X2n-6 into LCPs. In addition, since only about 35% of the tracer was found in plasma total lipids and as 13 CO 2 in breath, it might be necessary to study other accessible lipid fractions as well to study the overall conversion of linoleic acid.